Reported May 26, 2021 · Ongoing

Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only,…

Preferred Pharmaceuticals, Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Preferred Pharmaceuticals, Inc. · 1250 N Lakeview Ave Ste O · Anaheim, CA · 92807-1801

Is this the product you have?

  • Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only
  • Pkg Size100
  • MfgTime-Cap Labs Inc.; Farmingdale NY, NDC #: 68788-6932-1
Lot codes and dates
  • Lot Codes
    • C2520W
    • Exp.12/31/2021
    • E0620F
    • Exp. 12/31/2021
    • G2020M
    • Exp. 4/30/2022
    • G2720A
    • Exp. 4/30/2022
Amount recalled
147 bottles (14,700 extended release tablets)

Where it was sold

Why it was recalled

CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Preferred Pharmaceuticals, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 8:07 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.